263 related articles for article (PubMed ID: 30167776)
1. Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
Ondruschka B; Woydt L; Bernhard M; Franke H; Kirsten H; Löffler S; Pohlers D; Hammer N; Dreßler J
Int J Legal Med; 2019 May; 133(3):871-881. PubMed ID: 30167776
[TBL] [Abstract][Full Text] [Related]
2. Acute phase response after fatal traumatic brain injury.
Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
[TBL] [Abstract][Full Text] [Related]
3. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
[TBL] [Abstract][Full Text] [Related]
4. Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis.
Çatlı G; Anık A; Acar S; Küme T; Karabulut M; Çalan ÖG; Dündar BN; Abacı A
Pediatr Diabetes; 2018 Aug; 19(5):1000-1006. PubMed ID: 29484801
[TBL] [Abstract][Full Text] [Related]
5. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
[TBL] [Abstract][Full Text] [Related]
6. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
[TBL] [Abstract][Full Text] [Related]
7. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids.
Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J
J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Park SH; Hwang SK
World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
[TBL] [Abstract][Full Text] [Related]
10. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
[TBL] [Abstract][Full Text] [Related]
11. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.
Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749
[TBL] [Abstract][Full Text] [Related]
13. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
14. Multiple indicators model of long-term mortality in traumatic brain injury.
Gradisek P; Osredkar J; Korsic M; Kremzar B
Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum Neuron-specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder.
Esnafoglu E; Ayyıldız SN; Cırrık S; Erturk EY; Erdil A; Daglı A; Noyan T
Int J Dev Neurosci; 2017 Oct; 61():86-91. PubMed ID: 28711670
[TBL] [Abstract][Full Text] [Related]
16. Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid.
Zwirner J; Bohnert S; Franke H; Garland J; Hammer N; Möbius D; Tse R; Ondruschka B
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827575
[TBL] [Abstract][Full Text] [Related]
17. Glial and neuronal serum markers after controlled cortical impact injury in the rat.
Woertgen C; Rothoerl RD; Wiesmann M; Missler U; Brawanski A
Acta Neurochir Suppl; 2002; 81():205-7. PubMed ID: 12168305
[TBL] [Abstract][Full Text] [Related]
18. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis.
Rohlwink UK; Mauff K; Wilkinson KA; Enslin N; Wegoye E; Wilkinson RJ; Figaji AA
Clin Infect Dis; 2017 Oct; 65(8):1298-1307. PubMed ID: 28605426
[TBL] [Abstract][Full Text] [Related]
20. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G
J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
